We are live on ! Find out more
BPCE

Bank Pictet & Cie (Europe) Portfolio holdings

AUM $5.12B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+27.39%
3 Year Est. Return
+99.4%
5 Year Est. Return
+123.97%
10 Year Est. Return
+508.14%
AUM
$2.05B
AUM Growth
+$15.8M
Cap. Flow
-$99.8M
Cap. Flow %
-4.88%
Top 10 Hldgs %
44.82%
Holding
175
New
9
Increased
44
Reduced
72
Closed
13

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$16.8M
2
MSFT icon
Microsoft
MSFT
+$11.9M
3
ABBV icon
AbbVie
ABBV
+$11.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.03M
5
MCD icon
McDonald's
MCD
+$5.54M

Sector Composition

Rank Sector Weight
1 Healthcare 26.62%
2 Technology 13.9%
3 Consumer Discretionary 12.79%
4 Financials 11.16%
5 Communication Services 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRA icon
126
Natera
NTRA
$45.5B
$441K 0.02%
10,979
+64
+0.6% +$2.64K
INTC icon
127
Intel
INTC
$509B
$431K 0.02%
16,300
-6,178
-27% -$172K
NFLX icon
128
Netflix
NFLX
$309B
$423K 0.02%
14,350
+3,000
+26% +$84.2K
ICLR icon
129
Icon
ICLR
$12.9B
$422K 0.02%
+2,170
New +$430K
SHEL icon
130
Shell
SHEL
$249B
$416K 0.02%
7,300
INDA icon
131
iShares MSCI India ETF
INDA
$6.58B
$408K 0.02%
9,774
-1,053
-10% -$44.6K
BOTZ icon
132
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.59B
$401K 0.02%
19,525
ARWR icon
133
Arrowhead Research
ARWR
$12.3B
$385K 0.02%
9,488
+138
+1% +$4.57K
APLS
134
DELISTED
Apellis Pharmaceuticals
APLS
$376K 0.02%
7,262
-35
-0.5% -$1.86K
RGEN icon
135
Repligen
RGEN
$9.35B
$371K 0.02%
2,189
+345
+19% +$62.6K
VCSH icon
136
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$363K 0.02%
4,832
ECL icon
137
Ecolab
ECL
$78.1B
$361K 0.02%
2,482
+254
+11% +$37.3K
SGEN
138
DELISTED
Seagen Inc. Common Stock
SGEN
$340K 0.02%
2,644
+970
+58% +$125K
HCA icon
139
HCA Healthcare
HCA
$89.8B
$337K 0.02%
+1,406
New +$315K
XBI icon
140
State Street SPDR S&P Biotech ETF
XBI
$10.5B
$330K 0.02%
3,974
URTH icon
141
iShares MSCI World ETF
URTH
$8.35B
$323K 0.02%
2,956
AGG icon
142
iShares Core US Aggregate Bond ETF
AGG
$138B
$321K 0.02%
3,312
IRTC icon
143
iRhythm Holdings
IRTC
$4.13B
$318K 0.02%
3,391
+910
+37% +$99K
WDAY icon
144
Workday
WDAY
$43.3B
$311K 0.02%
1,858
ACN icon
145
Accenture
ACN
$110B
$307K 0.02%
1,149
-80,000
-99% -$22.1M
CSTL icon
146
Castle Biosciences
CSTL
$960M
$297K 0.01%
12,618
-3,339
-21% -$77.4K
PRGO icon
147
Perrigo
PRGO
$1.76B
$295K 0.01%
8,650
ORCL icon
148
Oracle
ORCL
$442B
$281K 0.01%
3,433
QURE icon
149
uniQure
QURE
$3.13B
$276K 0.01%
+12,192
New +$263K
XOM icon
150
ExxonMobil
XOM
$657B
$267K 0.01%
2,425

Similar funds

Bank Pictet & Cie (Europe)'s Q4 2022 Portfolio in Review

As of Q4 2022, Bank Pictet & Cie (Europe) held 175 positions worth $2.05B, up 0.78% from $2.03B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Bank Pictet & Cie (Europe) withdrew a net $99.8M in Q4 2022, closing 13 positions and reducing 72 holdings. Its most notable exit was WisdomTree Europe Hedged Equity Fund, an estimated $1.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bank Pictet & Cie (Europe) opened a new position in Neogen worth $1.03M.

  • Bank Pictet & Cie (Europe)'s largest Q4 2022 buy was Neogen: 67,550 shares worth $1.03M.
  • Bank Pictet & Cie (Europe) added most to Moderna in Q4 2022, an estimated $16.8M increase.
  • Bank Pictet & Cie (Europe)'s biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $22.2M.
  • Bank Pictet & Cie (Europe) fully exited WisdomTree Europe Hedged Equity Fund in Q4 2022, selling an estimated $1.01M.
  • Bank Pictet & Cie (Europe)'s ten largest holdings make up 45% of its $2.05B portfolio in Q4 2022.
  • Bank Pictet & Cie (Europe) opened 9 new positions and closed 13 in Q4 2022.
  • Bank Pictet & Cie (Europe)'s portfolio value rose 0.78% quarter-over-quarter to $2.05B.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2022, filed 8 Feb 2023.